MAY 23, 2019 10:10 PM PDT

Repurposing Cancer Drug for Treating Brain Aneurysms

WRITTEN BY: Nouran Amin

Brain aneurysms is a result of a bulging blood vessel due to a weakness in the blood vessel wall. When the blood passes through the weakened vessel walls, blood pressure will cause a small area to bulge outwards. These bulges can develop anywhere but most commonly in the abdominal aorta and the brain.

Learn more about aneurysms:

Treating a brain aneurysm is a challenge and involves complex surgery that has been attempted in select cases most notably Game of Thrones actress Emilia Clarke who suffered from two aneurysms while filming the series.

Now, new research points to a critical drug class used in the treatment of cancer patients in its potential to be repurposed for treating brain aneurysms. The class of drug is known as 'Receptor tyrosine kinase inhibitors' and can target the genetic basis of brain aneurysm—which involve mutations in the gene PDGFRB.

"This is an extremely exciting discovery which shows how basic lab-derived observations on a genetic level can move into a clinical setting and start making big changes to public healthcare and treatments,” says Mark O'Driscoll, Professor of Human Molecular Genetics at the Genome Damage and Stability Centre at the University of Sussex.

A 3D reconstruction of an angiogram showing the aneurysm circled in red. Credit: University of Sussex

"Our research focused primarily on understanding the genetic and cellular mechanisms underlying a particular type of aneurysm. By finding a new genetic basis in some patients, we were also able to demonstrate that a known cancer drug could counter this genetic basis in most instances. Understanding the genetics behind diseases like this is crucial in identifying possible treatments and next steps -- and that is exactly what our part in this new research has shown. The lead authors and our collaborators on this paper based in the US, are now working on the next stages to test this drug further."

Drug repurposing is not new to research and many studies have attempted to use FDA-approved drugs for the treatment of other disorders. Other drug repurposing stories have been successful with even dangerous drugs like thalidomide for treating leprosy.

"We are now very close to treating these aneurysm patients with PDGFRB variants with specific receptor tyrosine kinase inhibitors,” says lead author of the study, Dr. Manuel Ferreira of the University Of Washington School Of Medicine.

Findings of the study were published in the American Journal of Human Genetics.

Source: University of Sussex

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 21, 2020
Cancer
JAN 21, 2020
How caloric restriction mimetics might prove helpful for cancer treatments
The benefits of fasting have been known to scientists and medical professionals for some time now, however for many, the reality of fasting is not alluring...
JAN 21, 2020
Microbiology
JAN 21, 2020
The Mechanism of Lysostaphin, a MRSA-Killing Enzyme, is Revealed
This study can help inform the development of new treatments for antibiotic-resistant microbes....
JAN 21, 2020
Microbiology
JAN 21, 2020
Hybrid Antibiotic Can Destroy Dangerous Staph Biofilms
When staph begins to grow on medical devices like implants used on wounds, artificial joints, or catheters, they can cause chronic, serious infections....
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Improving Vaccines for Meningitis
Scientists at the University of Nottingham are seeking new ways to improve vaccine use in the protection against the bacterium, Neisseria meningitides that...
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Eye Solution Approved for Surgical Application
As announced by the Dutch Ophthalmic Research Center in a press release, a new eye solution was recently approved by the US Food and Drug Administration fo...
JAN 21, 2020
Cell & Molecular Biology
JAN 21, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact....
Loading Comments...